Genetically engineered PD-1 displaying nanovesicles for synergistic checkpoint blockades and chemo-metabolic therapy against non-small cell lung cancer.
Li B, Yang T, Liu J, Yu X, Li X, Qin F, Zheng J, Liang J, Zeng Y, Zhou Z, Liu L, Zhang B, Yao W, Feng Z, Zeng G, Zhou Q, Chen L.
Li B, et al. Among authors: yao w.
Acta Biomater. 2023 Apr 15;161:184-200. doi: 10.1016/j.actbio.2023.03.002. Epub 2023 Mar 7.
Acta Biomater. 2023.
PMID: 36893957
Free article.